• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Tanimura Keiko  谷村 恵子

Researcher Number 10768807
Other IDs
  • ORCIDhttps://orcid.org/0000-0002-7826-4466
Affiliation (Current) 2025: 京都府立医科大学, 医学(系)研究科(研究院), 研修員
Affiliation (based on the past Project Information) *help 2021 – 2023: 京都府立医科大学, 医学(系)研究科(研究院), 研修員
2020: 京都府立医科大学, 医学(系)研究科(研究院), 研究員
Review Section/Research Field
Principal Investigator
Basic Section 50010:Tumor biology-related / 0901:Oncology and related fields
Keywords
Principal Investigator
HER3 / 治療抵抗性 / がん分子標的治療 / 肺癌 / RET阻害薬 / RET-TKI / YAP / RET / 治療抵抗性細胞 / 非小細胞肺がん … More / Drug tolerant / 間葉系 / ALK阻害薬 / vimentin / alectinib / 間葉上皮転換 / 肺がん / ALK Less
  • Research Projects

    (2 results)
  • Research Products

    (4 results)
  • Co-Researchers

    (3 People)
  •  Elucidation and overcoming the drug tolerant mechanism in RET-altered cancerPrincipal Investigator

    • Principal Investigator
      Tanimura Keiko
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Elucidation and overcoming the drug tolerant mechanism in ALK-rearranged lung cancerPrincipal Investigator

    • Principal Investigator
      Tanimura Keiko
    • Project Period (FY)
      2020 – 2021
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Kyoto Prefectural University of Medicine

All 2022 2021 2020

All Journal Article Presentation

  • [Journal Article] HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.2022

    • Author(s)
      Tanimura K, Yamada T, Okada K, Nakai K, Horinaka M, Katayama Y, Morimoto K, Ogura Y, Takeda T, Shiotsu S, Ichikawa K, Watanabe S, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Taniguchi H, Yoneda K, Matoba S, Sakai T, Uehara H, Yano S, Kusaba T, Katayama R, Takayama K.
    • Journal Title

      NPJ Precis Oncol.

      Volume: 6 Issue: 1 Pages: 5-5

    • DOI

      10.1038/s41698-021-00250-8

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K08608, KAKENHI-PROJECT-20K21554, KAKENHI-PROJECT-20K22820, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03524, KAKENHI-PROJECT-19H03889, KAKENHI-PROJECT-20K08640
  • [Presentation] Overcoming drug tolerance to ALK inhibitor in ALK positive lung cancer2021

    • Author(s)
      Keiko Tanimura
    • Organizer
      The 25th Congress of the Asian Pacific Society of Respirology
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K22820
  • [Presentation] Novel therapeutic strategy with co-inhibition of ALK and HER3 signal in ALK-rearranged lung cancer2021

    • Author(s)
      Tanimura K, Yamada T, Okada K, Yoneda K, Horinaka M, Sakai T, Uehara H, Yano S, Katayama R, Takayama K
    • Organizer
      第80回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-20K22820
  • [Presentation] ALK融合遺伝子陽性肺がんのHER3活性を介したALK-TKI初期治療抵抗性の解明2020

    • Author(s)
      谷村恵子
    • Organizer
      第61回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-20K22820
  • 1.  YAMADA Tadaaki
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 2.  内野 順治
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 3.  高山 浩一
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi